Gil Blum
Stock Analyst at Needham
(4.61)
# 270
Out of 4,502 analysts
264
Total ratings
55.94%
Success rate
23.22%
Average return
Main Sectors:
Top Industries:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSHA Taysha Gene Therapies | Reiterates: Buy | $7 | $2.30 | +204.35% | 20 | Jul 26, 2024 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $31 → $29 | $21.96 | +32.09% | 17 | Jul 12, 2024 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $42 | $17.43 | +140.96% | 5 | Jul 8, 2024 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $53 → $52 | $25.41 | +104.64% | 14 | Jun 28, 2024 | |
| NKTX Nkarta | Reiterates: Buy | $13 | $7.01 | +85.45% | 12 | Jun 28, 2024 | |
| SRPT Sarepta Therapeutics | Reiterates: Buy | n/a | $144.32 | - | 22 | Jun 27, 2024 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $88 | $57.98 | +51.78% | 15 | Jun 27, 2024 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $17 | $8.36 | +103.47% | 15 | Jun 25, 2024 | |
| GTHX G1 Therapeutics | Maintains: Buy | $12 → $6 | $3.93 | +52.67% | 17 | Jun 25, 2024 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $9 | $4.69 | +91.90% | 19 | Jun 17, 2024 | |
| STTK Shattuck Labs | Maintains: Buy | $12 → $8 | $4.42 | +81.20% | 12 | Jun 14, 2024 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $6 → $7 | $4.16 | +68.47% | 11 | Jun 12, 2024 | |
| GERN Geron | Maintains: Buy | $5 → $6 | $4.65 | +29.03% | 16 | Jun 7, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $81 | $40.33 | +100.84% | 7 | Jun 3, 2024 | |
| CELC Celcuity | Maintains: Buy | $24 → $23 | $18.78 | +22.47% | 10 | May 31, 2024 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $10 | $3.50 | +185.71% | 11 | May 14, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $11 | $7.25 | +51.72% | 1 | May 13, 2024 | |
| ACLX Arcellx | Reiterates: Buy | $81 | $64.52 | +25.54% | 16 | May 10, 2024 | |
| FOLD Amicus Therapeutics | Reiterates: Hold | n/a | $10.19 | - | 2 | May 10, 2024 | |
| NXTC NextCure | Reiterates: Buy | $4 | $1.63 | +145.40% | 8 | May 3, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $6 | $1.35 | +344.44% | 12 | Apr 12, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $5.43 | - | 2 | Apr 11, 2024 |
Taysha Gene Therapies
Jul 26, 2024
Reiterates: Buy
Price Target: $7
Current: $2.30
Upside: +204.35%
Nurix Therapeutics
Jul 12, 2024
Maintains: Buy
Price Target: $31 → $29
Current: $21.96
Upside: +32.09%
Cartesian Therapeutics
Jul 8, 2024
Reiterates: Buy
Price Target: $42
Current: $17.43
Upside: +140.96%
Rocket Pharmaceuticals
Jun 28, 2024
Maintains: Buy
Price Target: $53 → $52
Current: $25.41
Upside: +104.64%
Nkarta
Jun 28, 2024
Reiterates: Buy
Price Target: $13
Current: $7.01
Upside: +85.45%
Sarepta Therapeutics
Jun 27, 2024
Reiterates: Buy
Price Target: n/a
Current: $144.32
Upside: -
CRISPR Therapeutics AG
Jun 27, 2024
Reiterates: Buy
Price Target: $88
Current: $57.98
Upside: +51.78%
Recursion Pharmaceuticals
Jun 25, 2024
Reiterates: Buy
Price Target: $17
Current: $8.36
Upside: +103.47%
G1 Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $12 → $6
Current: $3.93
Upside: +52.67%
Autolus Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $9
Current: $4.69
Upside: +91.90%
Shattuck Labs
Jun 14, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $4.42
Upside: +81.20%
Mereo BioPharma Group
Jun 12, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $4.16
Upside: +68.47%
Geron
Jun 7, 2024
Maintains: Buy
Price Target: $5 → $6
Current: $4.65
Upside: +29.03%
Immunocore Holdings
Jun 3, 2024
Reiterates: Buy
Price Target: $81
Current: $40.33
Upside: +100.84%
Celcuity
May 31, 2024
Maintains: Buy
Price Target: $24 → $23
Current: $18.78
Upside: +22.47%
Generation Bio Co.
May 14, 2024
Reiterates: Buy
Price Target: $10
Current: $3.50
Upside: +185.71%
TScan Therapeutics
May 13, 2024
Reiterates: Buy
Price Target: $11
Current: $7.25
Upside: +51.72%
Arcellx
May 10, 2024
Reiterates: Buy
Price Target: $81
Current: $64.52
Upside: +25.54%
Amicus Therapeutics
May 10, 2024
Reiterates: Hold
Price Target: n/a
Current: $10.19
Upside: -
NextCure
May 3, 2024
Reiterates: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
I-Mab
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $1.35
Upside: +344.44%
Fate Therapeutics
Apr 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $5.43
Upside: -